跳至主要内容
临床试验/CTRI/2023/03/050766
CTRI/2023/03/050766尚未招募不适用

Effect of Narrow Band Ultraviolet-B treatment on bone mineral density and vitamin D levels in vitiligo

Keshavamurthy Vinay1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年1月4日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
1. Measurement of bone mineral density using dual-energy X-ray absorptiometry (DEXA) at baseline and after 24 weeks.

研究概览

简要总结

Whole body narrow band-ultraviolet B (NB-UVB) phototherapy is widely used to treat extensive and spreading vitiligo. NB-UVB phototherapy is known to cause disease stabilization as well as re-pigmentation. Several other benefits of NB-UVB, including reduction in risk of cerebrovascular and cardiovascular adverse events have been observed. Indirect impact of NB-UVB on bone mineral density has been reported in terms of reduction in risk of osteoporotic fractures. However, direct impact of NB-UVB on bone health has not been assessed before. The present study, we aim to assess the effect of Narrow Band Ultraviolet-B treatment on bone mineral density and vitamin D levels in vitiligo patients who have previously received corticosteroid therapy. Further, as corticosteroid-induced osteopenia/osteoporosis tends to improve on cessation of steroid therapy, a control group in which patient
will receive a non-steroidal disease stabilising agent (e.g., azathioprine, cyclosporine, methotrexate, etc.) with no known impact on bone mineral density will also be recruited.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Outcome Assessor Blinded

入排标准

年龄范围
12.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients of non-segmental vitiligo involving 10-50% of body surface area 2.Age 12-60 years 3.Unstable disease, defined as occurrence of new lesion(s), progression of existing lesion(s) or Koebnerization 4.Should have received corticosteroids in any dose for >3 months.

排除标准

  • 1.Patients of segmental vitiligo and universal vitiligo 2.Contraindication to use of NBUVB phototherapy including xeroderma pigmentosa, systemic lupus erythematosus and other photo-induced or photo-aggravated dermatoses 3.Intake of phototoxic drugs 4.History of skin malignancy, premalignant skin lesions and dysplastic naevi 5.Claustrophobia 6.Hepatic and renal dysfunction 7.Immunosuppression 8.Associated connective tissue diseases including but not limited to systemic lupus erythematosus, rheumatoid arthritis 9.Pregnancy and lactation.

结局指标

主要结局

1. Measurement of bone mineral density using dual-energy X-ray absorptiometry (DEXA) at baseline and after 24 weeks.

时间窗: Baseline | 24 weeks

2. Measurement of serum vitamin D levels at baseline and after 24 weeks

时间窗: Baseline | 24 weeks

次要结局

未报告次要终点

研究者

发起方
Keshavamurthy Vinay
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验